[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-Radioactive Nucleic Acid Labeling Product Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 107 pages | ID: GAF7A1ECB703EN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.

According to APO Research, The global Non-Radioactive Nucleic Acid Labeling Product market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Non-Radioactive Nucleic Acid Labeling Product key players include Thermo Fisher Scientific, Roche, Promega, etc. Global top three manufacturers hold a share over 40%.

United States is the largest market, with a share over 40%, followed by China

and Europe, both have a share about 35 percent.

In terms of product, DIG System is the largest segment, with a share about 33%. And in terms of application, the largest application is DNA Labeling, followed by RNA Labeling, Oligonucleotide Labeling.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Radioactive Nucleic Acid Labeling Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Radioactive Nucleic Acid Labeling Product.

The Non-Radioactive Nucleic Acid Labeling Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Radioactive Nucleic Acid Labeling Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Thermo Fisher Scientific
  • Roche
  • Promega
  • PerkinElmer
  • Agilent Technologies
  • General Electric
  • Enzo Biochem
  • Merck KGaA
  • Vector Labs
  • New England Biolabs
Non-Radioactive Nucleic Acid Labeling Product segment by Type
  • Biotin
  • DIG System
  • Fluorescent
  • Others
Non-Radioactive Nucleic Acid Labeling Product segment by Application
  • DNA Labeling
  • RNA Labeling
  • Oligonucleotide Labeling
Non-Radioactive Nucleic Acid Labeling Product Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Radioactive Nucleic Acid Labeling Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Radioactive Nucleic Acid Labeling Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Radioactive Nucleic Acid Labeling Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Radioactive Nucleic Acid Labeling Product manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-Radioactive Nucleic Acid Labeling Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
  1.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Estimates and Forecasts (2019-2030)
  1.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales Estimates and Forecasts (2019-2030)
1.3 Non-Radioactive Nucleic Acid Labeling Product Market by Type
  1.3.1 Biotin
  1.3.2 DIG System
  1.3.3 Fluorescent
  1.3.4 Others
1.4 Global Non-Radioactive Nucleic Acid Labeling Product Market Size by Type
  1.4.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Overview by Type (2019-2030)
  1.4.2 Global Non-Radioactive Nucleic Acid Labeling Product Historic Market Size Review by Type (2019-2024)
  1.4.3 Global Non-Radioactive Nucleic Acid Labeling Product Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
  1.5.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Type (2019-2024)
  1.5.2 Europe Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Type (2019-2024)
  1.5.3 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Type (2019-2024)
  1.5.4 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Type (2019-2024)
  1.5.5 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Type (2019-2024)

2 GLOBAL MARKET DYNAMICS

2.1 Non-Radioactive Nucleic Acid Labeling Product Industry Trends
2.2 Non-Radioactive Nucleic Acid Labeling Product Industry Drivers
2.3 Non-Radioactive Nucleic Acid Labeling Product Industry Opportunities and Challenges
2.4 Non-Radioactive Nucleic Acid Labeling Product Industry Restraints

3 MARKET COMPETITIVE LANDSCAPE BY COMPANY

3.1 Global Top Players by Non-Radioactive Nucleic Acid Labeling Product Revenue (2019-2024)
3.2 Global Top Players by Non-Radioactive Nucleic Acid Labeling Product Sales (2019-2024)
3.3 Global Top Players by Non-Radioactive Nucleic Acid Labeling Product Price (2019-2024)
3.4 Global Non-Radioactive Nucleic Acid Labeling Product Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Non-Radioactive Nucleic Acid Labeling Product Key Company Manufacturing Sites & Headquarters
3.6 Global Non-Radioactive Nucleic Acid Labeling Product Company, Product Type & Application
3.7 Global Non-Radioactive Nucleic Acid Labeling Product Company Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Non-Radioactive Nucleic Acid Labeling Product Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Non-Radioactive Nucleic Acid Labeling Product Players Market Share by Revenue in 2023
  3.8.3 2023 Non-Radioactive Nucleic Acid Labeling Product Tier 1, Tier 2, and Tier

4 NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT REGIONAL STATUS AND OUTLOOK

4.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Non-Radioactive Nucleic Acid Labeling Product Historic Market Size by Region
  4.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales in Volume by Region (2019-2024)
  4.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales in Value by Region (2019-2024)
  4.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Non-Radioactive Nucleic Acid Labeling Product Forecasted Market Size by Region
  4.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales in Volume by Region (2025-2030)
  4.3.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales in Value by Region (2025-2030)
  4.3.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales (Volume & Value), Price and Gross Margin (2025-2030)

5 NON-RADIOACTIVE NUCLEIC ACID LABELING PRODUCT BY APPLICATION

5.1 Non-Radioactive Nucleic Acid Labeling Product Market by Application
  5.1.1 DNA Labeling
  5.1.2 RNA Labeling
  5.1.3 Oligonucleotide Labeling
5.2 Global Non-Radioactive Nucleic Acid Labeling Product Market Size by Application
  5.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Overview by Application (2019-2030)
  5.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Historic Market Size Review by Application (2019-2024)
  5.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
  5.3.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Application (2019-2024)
  5.3.2 Europe Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Application (2019-2024)
  5.3.3 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Application (2019-2024)
  5.3.4 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Application (2019-2024)
  5.3.5 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales Breakdown by Application (2019-2024)

6 COMPANY PROFILES

6.1 Thermo Fisher Scientific
  6.1.1 Thermo Fisher Scientific Comapny Information
  6.1.2 Thermo Fisher Scientific Business Overview
  6.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.1.5 Thermo Fisher Scientific Recent Developments
6.2 Roche
  6.2.1 Roche Comapny Information
  6.2.2 Roche Business Overview
  6.2.3 Roche Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.2.4 Roche Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.2.5 Roche Recent Developments
6.3 Promega
  6.3.1 Promega Comapny Information
  6.3.2 Promega Business Overview
  6.3.3 Promega Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.3.4 Promega Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.3.5 Promega Recent Developments
6.4 PerkinElmer
  6.4.1 PerkinElmer Comapny Information
  6.4.2 PerkinElmer Business Overview
  6.4.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.4.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.4.5 PerkinElmer Recent Developments
6.5 Agilent Technologies
  6.5.1 Agilent Technologies Comapny Information
  6.5.2 Agilent Technologies Business Overview
  6.5.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.5.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.5.5 Agilent Technologies Recent Developments
6.6 General Electric
  6.6.1 General Electric Comapny Information
  6.6.2 General Electric Business Overview
  6.6.3 General Electric Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.6.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.6.5 General Electric Recent Developments
6.7 Enzo Biochem
  6.7.1 Enzo Biochem Comapny Information
  6.7.2 Enzo Biochem Business Overview
  6.7.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.7.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.7.5 Enzo Biochem Recent Developments
6.8 Merck KGaA
  6.8.1 Merck KGaA Comapny Information
  6.8.2 Merck KGaA Business Overview
  6.8.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.8.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.8.5 Merck KGaA Recent Developments
6.9 Vector Labs
  6.9.1 Vector Labs Comapny Information
  6.9.2 Vector Labs Business Overview
  6.9.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.9.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.9.5 Vector Labs Recent Developments
6.10 New England Biolabs
  6.10.1 New England Biolabs Comapny Information
  6.10.2 New England Biolabs Business Overview
  6.10.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
  6.10.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
  6.10.5 New England Biolabs Recent Developments

7 NORTH AMERICA BY COUNTRY

7.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country
  7.1.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.1.2 North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2024)
  7.1.3 North America Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Country (2025-2030)
7.2 North America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country
  7.2.1 North America Non-Radioactive Nucleic Acid Labeling Product Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.2.2 North America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country (2019-2024)
  7.2.3 North America Non-Radioactive Nucleic Acid Labeling Product Market Size Forecast by Country (2025-2030)

8 EUROPE BY COUNTRY

8.1 Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country
  8.1.1 Europe Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.1.2 Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2024)
  8.1.3 Europe Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Country (2025-2030)
8.2 Europe Non-Radioactive Nucleic Acid Labeling Product Market Size by Country
  8.2.1 Europe Non-Radioactive Nucleic Acid Labeling Product Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.2.2 Europe Non-Radioactive Nucleic Acid Labeling Product Market Size by Country (2019-2024)
  8.2.3 Europe Non-Radioactive Nucleic Acid Labeling Product Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC BY COUNTRY

9.1 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Country
  9.1.1 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.1.2 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2024)
  9.1.3 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size by Country
  9.2.1 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.2.2 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size by Country (2019-2024)
  9.2.3 Asia-Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA BY COUNTRY

10.1 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales by Country
  10.1.1 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.1.2 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2024)
  10.1.3 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Country (2025-2030)
10.2 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country
  10.2.1 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.2.2 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country (2019-2024)
  10.2.3 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST AND AFRICA BY COUNTRY

11.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales by Country
  11.1.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.1.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2024)
  11.1.3 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Size by Country
  11.2.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.2.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Size by Country (2019-2024)
  11.2.3 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Size Forecast by Country (2025-2030)

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS

12.1 Non-Radioactive Nucleic Acid Labeling Product Value Chain Analysis
  12.1.1 Non-Radioactive Nucleic Acid Labeling Product Key Raw Materials
  12.1.2 Key Raw Materials Price
  12.1.3 Raw Materials Key Suppliers
  12.1.4 Manufacturing Cost Structure
  12.1.5 Non-Radioactive Nucleic Acid Labeling Product Production Mode & Process
12.2 Non-Radioactive Nucleic Acid Labeling Product Sales Channels Analysis
  12.2.1 Direct Comparison with Distribution Share
  12.2.2 Non-Radioactive Nucleic Acid Labeling Product Distributors
  12.2.3 Non-Radioactive Nucleic Acid Labeling Product Customers

13 CONCLUDING INSIGHTS

14 APPENDIX

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
  14.5.1 Secondary Sources
  14.5.2 Primary Sources
14.6 Disclaimer


More Publications